Search

everythinglearnresearchcommunity

for

Search:↓

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

More biopsy cores and MRI before biopsy can improve prostate cancer detection.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Hair loss can be an early sign of prostate enlargement.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Diagnose PCOS in teens using irregular periods and high androgen levels, not ultrasound.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Male pattern baldness may predict prostate cancer risk.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Early hair loss may indicate prostate issues.

An alpaca acted like a male and couldn't have babies because of a benign tumor in its ovary that caused high testosterone levels.

Early hair loss may indicate future prostate issues.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Serum triglyceride levels are not linked to prostate cancer risk.

An mFG score of 5 or more indicates above-normal hair growth in Southern Chinese women.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.